Investment Banking
Deal Criteria
Sector Focus
Recent Transactions Investment Banking Team

Strong expertise in Life Sciences and Biotech

  • Experienced in working with companies ranging from Preclinical, Phase 1-3 trials, and Filing to FDA-approved companies
  • Public and late-stage private companies that require access to capital in order to grow

Unique scientific and technical insight into the intricacies of the very complex life sciences industry, including Biotechnology, Specialty Pharmaceuticals, Medical Devices and Diagnostics sub-sectors

Extensive relationships with highly-specialized healthcare investors and can have senior level access to most companies in the sector

We guide companies through myriad structures and forms of financing (private placements, registered offerings, M&A, confidentially-marketed offerings, etc.) and provide practical solutions for late-stage private companies seeking access to public markets through paths other than the traditional IPO

e-mail investmentbanking@benchmarkcompany.com



Member FINRA, SIPC , 2010 The Benchmark Company, LLC.  All rights reserved.